Digestive neuroendocrine tumours G1 and G2: Experience of the medical oncology department at the Oran University Hospital Establishment 1st November 1954

#4460

Introduction: The histological classification of neuroendocrine tumours (NETs) remains complex, and their grading is a major prognostic factor, essential for guiding appropriate management. Moreover, NETs raise unresolved histogenetic questions. The treatment of grade 1 (G1) NETs primarily relies on somatostatin analogues, while grade 2 (G2) NETs, being more heterogeneous, may require management that includes chemotherapy or targeted therapy.

Aim(s): The objective of this study is to describe the epidemiological and clinical characteristics of patients with G1 and G2 digestive NETs followed at EHU Oran, as well as to analyse the diagnostic and therapeutic approaches implemented.

Materials and methods: We conducted a retrospective study including 18 patients with G1 and G2 digestive NETs, managed in the medical oncology department at EHU Oran between January 2022 and December 2023. These patients were recruited from university hospital centres and public hospital establishments (EPH) in western Algeria. Patients with extra-digestive NETs were excluded from the analysis.

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Larbi Bounsbia L, Bechikh A,

Keywords: Digestive Neuroendocrine Tumour, Grade 1, Grade 2, Somatostatin Analogue,